Susanne Schrey-Petersen1, Holger Stepan2. 1. Department of Obstetrics and Gynecology, University of Leipzig Faculty of Medicine, Leipzig, Germany. susanne.schrey@medizin.uni-leipzig.de. 2. Department of Obstetrics and Gynecology, University of Leipzig Faculty of Medicine, Leipzig, Germany.
Abstract
PURPOSE OF REVIEW: Preeclampsia remains one of the most important complications in pregnancy worldwide. With this review, we aim to give an overview on important research findings over the last years and their effects on current clinical management. RECENT FINDINGS: The association between preeclampsia and altered angiogenesis is nowadays widely accepted. Only during the last years, assessment of angiogenic factors such as the soluble fms-like tyrosine kinase-1-to-placental growth factor (sFlt-1/PlGF) ratio has become available to everyday clinical practice with commercially available automated measurements. With these, preeclampsia can be confirmed or ruled out in uncertainty of diagnosis, and a short-term prognosis can be given in patients with symptoms of preeclampsia. Pilot studies show that maternal serum levels of sFlt-1 can be reduced by therapeutic apheresis and that this might prolong pregnancy in case of very early severe preeclampsia. The automated measurement of the sFlt-1/PlGF ratio is starting to influence clinical management of preeclampsia. Apheresis might offer new treatment options, but still needs to be evaluated in randomized trials.
PURPOSE OF REVIEW: Preeclampsia remains one of the most important complications in pregnancy worldwide. With this review, we aim to give an overview on important research findings over the last years and their effects on current clinical management. RECENT FINDINGS: The association between preeclampsia and altered angiogenesis is nowadays widely accepted. Only during the last years, assessment of angiogenic factors such as the soluble fms-like tyrosine kinase-1-to-placental growth factor (sFlt-1/PlGF) ratio has become available to everyday clinical practice with commercially available automated measurements. With these, preeclampsia can be confirmed or ruled out in uncertainty of diagnosis, and a short-term prognosis can be given in patients with symptoms of preeclampsia. Pilot studies show that maternal serum levels of sFlt-1 can be reduced by therapeutic apheresis and that this might prolong pregnancy in case of very early severe preeclampsia. The automated measurement of the sFlt-1/PlGF ratio is starting to influence clinical management of preeclampsia. Apheresis might offer new treatment options, but still needs to be evaluated in randomized trials.
Authors: Tejas V Patel; Jeffrey A Morgan; George D Demetri; Suzanne George; Robert G Maki; Michael Quigley; Benjamin D Humphreys Journal: J Natl Cancer Inst Date: 2008-02-12 Impact factor: 13.506
Authors: Marc U Baumann; Nick A Bersinger; Markus G Mohaupt; Luigi Raio; Susan Gerber; Daniel V Surbek Journal: Am J Obstet Gynecol Date: 2008-09 Impact factor: 8.661
Authors: D Schlembach; W Wallner; R Sengenberger; E Stiegler; M Mörtl; M W Beckmann; U Lang Journal: Ultrasound Obstet Gynecol Date: 2007-04 Impact factor: 7.299
Authors: Tinnakorn Chaiworapongsa; Jimmy Espinoza; Francesca Gotsch; Yeon Mee Kim; Gi Jin Kim; Luis F Goncalves; Samuel Edwin; Juan Pedro Kusanovic; Offer Erez; Nandor Gabor Than; Sonia S Hassan; Roberto Romero Journal: J Matern Fetal Neonatal Med Date: 2008-01
Authors: Saira Salahuddin; Young Lee; Mary Vadnais; Benjamin P Sachs; S Ananth Karumanchi; Kee-Hak Lim Journal: Am J Obstet Gynecol Date: 2007-07 Impact factor: 8.661
Authors: Sarosh Rana; Camille E Powe; Saira Salahuddin; Stefan Verlohren; Frank H Perschel; Richard J Levine; Kee-Hak Lim; Julia B Wenger; Ravi Thadhani; S Ananth Karumanchi Journal: Circulation Date: 2012-01-18 Impact factor: 29.690
Authors: Evelyn Klein; Dietmar Schlembach; Angela Ramoni; Elena Langer; Franz Bahlmann; Sabine Grill; Helene Schaffenrath; Reinhard van der Does; Diethelm Messinger; Wilma D J Verhagen-Kamerbeek; Manfred Reim; Martin Hund; Holger Stepan Journal: PLoS One Date: 2016-05-31 Impact factor: 3.240
Authors: Bradley Wallace; Amelie Peisl; Gregory Seedorf; Taylor Nowlin; Christina Kim; Jennifer Bosco; Jon Kenniston; Dennis Keefe; Steven H Abman Journal: Am J Respir Crit Care Med Date: 2018-03-15 Impact factor: 21.405
Authors: Juilee S Deshpande; Deepali P Sundrani; Akriti S Sahay; Sanjay A Gupte; Sadhana R Joshi Journal: Hypertens Res Date: 2021-04-01 Impact factor: 3.872